Stock Insights : Adani Enterprises Ltd, Adani Green Energy Ltd, Brigade Enterprises Ltd, JSW Energy Ltd, KPIT Technologies Ltd, Zydus Lifesciences Ltd - ARETE Securities Ltd
Market Updates
The markets are expected to open marginally higher today as trends in GIFT NIFTY indicate a positive start for the broader index after NIFTY closed 232 points lower at 24,363 on Friday.
Adani Enterprises
The company’s subsidiary Mundra Synenergy incorporated UP Syn-Gas & Chemicals and OD Syn-Gas & Chemicals as step-down wholly owned units in India.
Adani Green Energy
The company’s stepdown subsidiary commissioned a 50 MW solar-wind hybrid project at Khavda, Gujarat, raising total operational renewable capacity to 15,865.5 MW.
Goldiam International
The company received Rs.40 crore export orders from clients in Middle-East, Israel and USA for lab-grown diamond studded gold jewellery.
Brigade Enterprises
The company has launched Brigade Cherry Blossom, a strategic JV in Malur (East Bengaluru), with a total development area of 4.51 lakh sq ft and projected revenue potential of over Rs 225 crore.
HG Infra Engineering
The company and DEC Infrastructure received RLDA-appointed date for Rs.2,195.68 crore New Delhi Railway Station redevelopment EPC project over 45 months.
IDFC FIRST Bank
The company received RBI approval for Platinum Invictus B 2025 RSC to invest Rs.2,624 crore for a 5.09% post-issue stake.
Interarch Building Solutions
The company will set up a heavy fabrication and multistorey pre-engineered steel buildings unit in AP with Rs.80 crore investment.
JSW Energy
The company commissioned the final 80 MW unit of the 240 MW Kutehr Hydro Plant in Himachal Pradesh, supplying full capacity electricity to Haryana.
KPIT Technologies
The company revised Caresoft acquisition to $157 million, raised N-Dream stake to 51%, and invested $10 million in Helm.ai for SDV focus.
Samvardhana Motherson International
The company incorporated a wholly owned subsidiary Motherson New Energy to design, develop and operate renewable-based power, energy and infrastructure projects for captive use.
Zydus Lifesciences
The company received USFDA final approval for Prucalopride Tablets, 1 mg and 2 mg, with $186.8 million US annual sales.
Please refer disclaimer at http://www.aretesecurities.com/
SEBI Regn. No.: INM0000127
